Michel A. Duchosal
Swiss HIV Cohort Study(CH)
Publications by Year
Research Areas
Sirtuins and Resveratrol in Medicine, Biochemical and Molecular Research, Chronic Myeloid Leukemia Treatments, PARP inhibition in cancer therapy, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib(2010)261 cited
- → The NAD-Booster Nicotinamide Riboside Potently Stimulates Hematopoiesis through Increased Mitochondrial Clearance(2019)209 cited
- → Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry(2009)202 cited
- → Population pharmacokinetics of imatinib and the role of α1‐acid glycoprotein(2006)192 cited
- → The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies(2009)186 cited
- → Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice.(1990)152 cited